Who's the daddy? US sperm banks must be better regulated
By Alison Motluk,
New Scientist
| 08. 09. 2007
CAREFUL,
exacting, high-tech - that's the image US sperm banks like to project
to their customers. They run limited genetic tests on their donors and
trace medical records back three generations. They also screen for
chemical exposure, drug use and even do complex psychological profiling.
Equally
interesting is what sperm banks don't do - and are not required to do
by law. They don't verify that all the medical or personal information
that donors give them is correct. They don't routinely test for the
majority of known genetic diseases. They do not confirm that the sperm
the woman requested is the sperm that ends up in her body. And they
don't always know where to find donors or recipient families should a
concern crop up.
Now
a small, not-for-profit company is beginning to fill in these gaps. In
doing so, it threatens to expose just how common errors in the American
fertility industry might be, and how little oversight exists to stop
these problems from happening or to deal with them if they do occur.
In January this year, the...
Related Articles
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...
By Antonia O'Flaherty, ABC News Australia | 03.04.2026
Fertility giant Monash IVF has agreed to pay financial settlements to families involved in two major bungles that saw two women transferred the wrong embryo.
In February 2025 the company became aware that one of its Brisbane clinic's patients had...
By Dr. Marcin Śmietana, Progress Educational Trust (PET) | 03.02.2026
When a family created through surrogacy abroad returns to their home country after the birth of the child, the genetic parent(s) are usually recognised as legal parents by default. However, any parent without a genetic link to the child needs...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...